What’s the difference between genetic engineering and eugenics?
By Robert Gebelhoff,
The Washington Post
| 02. 22. 2016
Untitled Document
For a half-century, the ethics of human genetic engineering have been discussed in the abstract. Because the tools to edit DNA didn’t exist, the question was more a thought experiment than a real concern.
Today, though, the conversation has completely changed. There has been a frenzy of excitement around the possibilities of CRISPR-Cas9. The technology, which allows scientists to design proteins that unzip and replace chunks of DNA as they please, makes it possible to edit genes quickly and cheaply. Investors have poured hundreds of millions of dollars into the innovation, which seems to have endless possibilities: making crops more resilient to diseases, designing mosquitoes so they can’t carry malaria — maybe even eliminating diseases among humans by altering the genes we pass on.
Scientists are confident that the technology could one day eliminate genetic disorders in humans. However, the research is still very young, and there are major ethical questions attached to editing human DNA that the emergence of CRISPR makes even more pressing: Wouldn’t editing out inheritable traits from the human population simply amount to eugenics...
Related Articles
By Grace Won, KQED [with CGS' Katie Hasson] | 12.02.2025
In the U.S., it’s illegal to edit genes in human embryos with the intention of creating a genetically engineered baby. But according to the Wall Street Journal, Bay Area startups are focused on just that. It wouldn’t be the first...
Several recent Biopolitical Times posts (1, 2, 3, 4) have called attention to the alarmingly rapid commercialization of “designer baby” technologies: polygenic embryo screening (especially its use to purportedly screen for traits like intelligence), in vitro gametogenesis (lab-made eggs and sperm), and heritable genome editing (also termed embryo editing or reproductive gene editing). Those three, together with artificial wombs, have been dubbed the “Gattaca stack” by Brian Armstrong, CEO of the cryptocurrency company...
By Lucy Tu, The Guardian | 11.05.2025
Beth Schafer lay in a hospital bed, bracing for the birth of her son. The first contractions rippled through her body before she felt remotely ready. She knew, with a mother’s pit-of-the-stomach intuition, that her baby was not ready either...
By Emily Glazer, Katherine Long, Amy Dockser Marcus, The Wall Street Journal | 11.08.2025
For months, a small company in San Francisco has been pursuing a secretive project: the birth of a genetically engineered baby.
Backed by OpenAI chief executive Sam Altman and his husband, along with Coinbase co-founder and CEO Brian Armstrong, the startup—called...